All posts by imreal

myButterfly.AI kicks off Crowd Funding Campaign on StartEngine


myButterfly.AI announces the launch of their Regulation CrowdFunding capital raise, on the StartEngine platform. myButterfly.AI is seeking to raise capital to pay for the development of its patent pending proprietary AI patient centered health app.

This app is being developed to comprehend medical conversations and transform them into plain language that the layperson can understand – and in the native language of the patient. This app is also being developed to smart shop for products that are recommended to the patient by their physician, and using myButterfly.AI’s proprietary supply mesh IP to intelligently source products, even if they are in supply shock.

“Academic studies, news reporting and anecdotal accounts from physicians shows a link between creating engaged patients and better healthcare outcomes. We believe our proprietary AI driven app will help activate patients and get them engaged in their care, while giving them autonomy as a consumer to pay less for the therapies they need,” said myButterfly.AI CoFounder & CEO Sam Adams.

Note to editors: The following disclaimer should be included in any content covering this raise per SEC Regulation regarding Reg CF Equity Crowdfunding:

DISCLAIMER: myButterfly.AI is offering securities through the use of an Offering Statement that has been qualified by the Securities and Exchange Commission under Regulation CrowdFunding. A copy of the Final Offering Circular that forms a part of the Offering Statement may be obtained from: https://www.startengine.com/mybutterfly.ai.

For questions contact myButterfly.AI at info@mybutterfly.ai

Share article on social media or email:

National Nutrition Partners with SUKU Vitamins to Offer Full Line of SUKU Gummy Vitamins


Clear skin starts from within – National Nutrition dot CA has just announced its most recent partnership with SUKU Vitamins. National Nutrition is Canada’s leading vitamin and supplement shop and SUKU Vitamins is a Naturopathic formulated Canadian gummy vitamin company.

The Original Sugar-Free Gummies

SUKU Vitamins is a Naturopathic formulated company from Toronto, Ontario. From the beginning, SUKU Vitamins partnered with leading nutritionists and naturopathic doctors to ensure that their formulas would be science-backed and made with ingredients that work. SUKU Vitamins doesn’t stop there, all products are tested three times at different stages throughout the manufacturing process for purity.

Consumers love SUKU Vitamins for their great taste. All SUKU gummies are sugar-free, free from sugar alcohols and contain no artificial colours or flavours and are all made in Canada.

The Full Line of SUKU Gummy Vitamins Now Available at National Nutrition

With this new partnership, all SUKU gummy vitamins will now be available at National Nutrition, including the bestselling gummies Applely Ever After and Luscious Hair. Applely Ever After gummies provides one serving of apple cider vinegar in a convenient and fun-to-take gummy. SUKU’s Luscious Hair combo combines seven nutrients, including silicon, biotin and hydrolyzed marine collagen for healthy hair, skin and nails.

Science-Backed Supplements that are FUN to Take

Darren Firth, National Nutrition’s CEO says: “It’s unusual to discover a line of products that are science-based and fun to take. SUKU Vitamins provides the best of both worlds, efficacious, clean products that customers really enjoy taking.”

He continues: “National Nutrition’s customers already love SUKU gummies and we know they’ll love the expanded selection of great products.”

SUKU Vitamins’ CEO, Ju Young Yoo says: “Having a naturopathic medicine background, I know what it takes to formulate a great product. I am excited about this partnership with National Nutrition as I know that their wonderful staff will help to educate customers and show them that delicious, clean and sugar-free vitamins can also be fun to take.”

National Nutrition’s full selection of SUKU Vitamins can be viewed in their dedicated department SUKU Vitamin supplements.

About National Nutrition

National Nutrition dot CA is Canada’s industry-leading online vitamin & supplement store. They’ve received many awards from the Canadian Health Food Association for being Canada’s best natural health food store and have been customer-focused for over 25 years. Not only do they provide high-quality brands and supplements, but National Nutrition dot CA also empowers their customers with natural health knowledge by leading industry experts communicated through videos on its Youtube channel and health-related articles on its website.

Share article on social media or email:

Camp Lejeune Toxic Water And How It May Affect Rhode Island And Massachusetts Legal Rights


“I am in the midst of meetings and learning more about how this national litigation will play out,” said Mike Bottaro, Founder of The Bottaro Law Firm.

Marine Corps Base Camp Lejeune appears to be one of the worst water contaminant sites in history. There are estimations that from 1953 to 1987, millions of American veterans, families, and workers were exposed to this toxic contaminated water at the Camp Lejeune base. The level of volatile organic compounds found in the Camp Lejeune water supply has been reported to cause a wide array of harm and personal injuries to those exposed. On August 10, 2022, President Biden enacted the Honoring Our PACT Act, which gives military veterans and others around Camp Lejeune the right to compensation for harm caused by water contamination.

The PACT Act can help those in our Rhode Island and Massachusetts communities in several ways. The law expands access to health care and health screenings. Additionally, for the first time, it permits those harmed by the contaminated water at Camp Lejeune to file lawsuits against the federal government seeking compensation.

Here are just some of the potential harms for which Camp Lejeune victims could be entitled to compensation:


  • Cancer: Liver, Bladder Cancer, Thyroid, etc.
  • Birth Defects
  • Leukemia
  • Brain Cancer
  • Thyroid Cancer
  • Multiple Myeloma
  • Parkinson’s Disease
  • Scleroderma
  • Aplastic Anemia
  • Hepatic Steatosis
  • Cardiac Defects
  • Neurobehavioral Disorders

In preparation to help support the veterans throughout Rhode Island and Massachusetts communities, Attorney Mike Bottaro is attending meetings, talking with veterans, and learning more about how this national litigation will play out.

“I am in the midst of meetings and learning more about how this national litigation will play out,” said Mike Bottaro, Founder of The Bottaro Law Firm. “The new law gives the legal right to monetary compensation to potentially millions of Americans, alive or who have already passed. Veterans, widows, and others now have important, new legal rights. Your case will likely get consolidated into out-of-state federal litigation. If you live in our communities here in Rhode Island and in Southeastern Massachusetts you need a local, trusted personal injury law firm. At Bottaro Law, we offer you the advantage of that local voice so you do not get lost with a nameless, national out-of-state firm”

About The Bottaro Law Firm, LLC.

Attorney Mike Bottaro and his team handle all types of personal injury cases including Camp Lejeune cases throughout Rhode Island and Massachusetts. Inside the courtroom, they have been recognized by their peers for their trial advocacy, ethics, and professionalism throughout RI and MA. Bottaro Law’s guiding principle is the Golden Rule: Doing the right thing for their clients. Call or text Bottaro Law 24/7 for live help with a free case review at (401) 777-7777.

Share article on social media or email:

‘Starting’ of FDA Registration and Approval Process for OLED Patch with Sewon E&C and Photonic-Bio in South Korea


Compartments of OLED Patch

Announced on the August, 25th, Sewon E&C and Photonic-Bio began the process of registering and approving flexible OLED (organic light-emitting diode) patches that can be attached to the body to help treat pain and skin regeneration for patients and the elderly.

Sewon E&C, which has obtained exclusive rights to manufacture and sell, and Photonic-Bio, which has transferred technologies from KAIST(Korea Advanced Institute of Science and Technology), are expected to go into business in Korea and to take appropriate steps for U.S. FDA before entering the U.S. market in earnest.

OLED patches use OLED as a light source to uniformly radiate a large target area. They are very thin and flexible, so the patches have a unique advantage of having a flexible form which make them wearable without causing inconvenience in daily life.

Phototherapy is a treatment that promotes the biochemical reaction of the human body through light-emission. By combining flexible OLED technology with phototherapy, the OLED patches will become innovative medical and beauty product that can be attached to the body.

As South Korea being the leading country in OLED display technology, the company expects that this product can lead markets and large-scale industries by combining phototherapy and OLED technology to commercialize a treatment that is portable and in high efficiency.

Photonic-Bio’s OLED light patch utilizes a free-form platform that can be attached freely. It is less than 1mm thick and weighs less than 1g. In addition, it lasts more than 300 hours after charging, and can perform in a bent shape within the radius of 20mm, making it possible to be attached to various body parts. Also, it only operates at temperatures below 42℃, meeting the stability standard of low-temperature burns based on the International Organization for Standardization (ISO).

An official from Sewon E&C said, “OLED patch confirmed excellent effects on wound healing through preclinical trials in the first half of this year. In addition, we plan to expand its application to medical fields such as dementia, skin cancer, pain treatment, skin regeneration, wrinkle improvement, and skin disease improvement.”

Share article on social media or email:

ASHA Announces 2022 Media Champion Award Recipients for Outstanding Coverage and Outreach About Communication Disorders


“We thank and honor this year’s recipients for highlighting topics and areas where audiologists and speech-language pathologists play major roles and can make a positive difference.”

The American Speech-Language-Hearing Association (ASHA) announced the recipients of ASHA’s 2022 Media Champion Award today, which is presented to media outlets, ASHA members, and others for outstanding coverage and outreach about communication disorders and the work of communication professionals.

“We thank and honor this year’s recipients for highlighting topics and areas where audiologists and speech-language pathologists play major roles and can make a positive difference,” said ASHA 2022 President Judy Rich, EdD, CCC-SLP, BCS-CL.

ASHA’s 2022 Media Champion Award recipients are listed below:

U.S. News & World Report: For “Talk Tool: Teletherapy Vital for Kids’ Speech Skills During COVID-19,” by Steven Ross Johnson, published December 16, 2021. Johnson consulted several ASHA members and staff for a comprehensive story about the benefits of teletherapy for students with communication disorders during school closures.

Agence France-Presse (AFP): For “What is aphasia? Here’s what you need to know” (published March 30, 2022) and “Masks in class — how damaging to child development?” (published February 10, 2022). AFP published a primer on aphasia following the announcement of actor Bruce Willis’s diagnosis with the language disorder and compiled expert opinions regarding the effect of mask use on the development of children.

The New Republic: For “What Do Masks Do to Kids?” by Melody Schreiber, published February 7, 2022. The coverage featured the perspectives of childhood development experts concerning children’s mask use.

Florida News Network: For its broadcast coverage about July 4th hearing protection from fireworks. ASHA member Ianthe Dunn-Murad, ScD, CCC-A, shared steps to prevent noise-induced hearing loss.

Fox 11 – Los Angeles: For its March 4, 2022, coverage of World Hearing Day. ASHA member Marquitta Merkison, AuD, CCC-A, spoke about various ways to protect hearing—and how to identify and prevent hearing loss.

The Pulse: For its November 26, 2021, podcast episode, “Trouble understanding, but your hearing checks out fine. What’s at play?” by Liz Tung. The podcast featured ASHA member Lindsey Jorgensen, AuD, PhD, who spoke about the controversial topic of auditory processing disorder.

Verywell Family: For its May 19, 2022, article, “How Many Words Should My Child Be Saying?” by May Sofi. Sofi interviewed ASHA member Michelle Katsnelson, MS, CCC-SLP, about developmental milestones for children’s speech. The article also referenced guidelines from ASHA.

AARP: For three articles about hearing health that included guidance from ASHA member audiologists:

  •     6 Bad Habits for Your Hearing
  •     6 Habits for Healthy Ears at Any Age
  •     What You Need to Know About Sensorineural Hearing Loss

HealthDay: For its July 13, 2022, article “Finding Their Voice: For Trans People, Vocal Modification Can Be Key,” by Cara Murez. Murez spoke to ASHA member Anna Lichtenstein, MA, CCC-SLP, about her work as a gender-affirming voice modification therapist.

Fox News Digital: For its July 22, 2022, article “Special ed programs in public schools plagued by staffing shortages: Experts,” by Cortney O’Brien. O’Brien interviewed ASHA Associate Director of School Services in Speech-Language-Pathology Stacey Glasgow about the various struggles that have contributed to recent school staffing shortages.

Suzanne Coyle, MA, CCC-SLP: A video of Coyle providing services to an aphasia patient is part of a new word-finding exhibit at the Planet Word Museum, Washington, D.C. Coyle also served as a panelist for an online museum program about aphasia.

Rinki Desai, MS, CCC-SLP: Throughout the COVID-19 pandemic, Desai discussed how the disease can affect swallowing—and how SLP services can help. She was interviewed by Contagion Live, Health Leaders, and the Speech Uncensored podcast. She’s also been a regular media source on other swallowing issues, including a recent story on esophageal dysphagia for EverydayHealth.com.

Karen McQuaide, AuD, CCC-A: McQuaide has done several broadcast interviews related to World Hearing Day (March 3) and July 4th, where she has shared guidance about hearing health and protection.

Maria Pomponio, AuD, CCC-A: Pomponio was a significant contributor to AARP’s guide to protecting your hearing and avoiding hearing loss. An active ASHA volunteer, her areas of expertise include adult and pediatric hearing loss, auditory processing disorder, audiologic rehabilitation, and vestibular/balance assessment.

Planet Word Museum, Washington, D.C.: In collaboration with ASHA, the museum developed and launched a new interactive exhibit about word-finding problems. It also held and promoted a related hour-long virtual panel discussion.

Michael Settles: Settles appears in a video that is part of the new word-finding exhibit at the Planet Word Museum. The video shows him receiving therapy for aphasia. Settles also participated in a related online museum-hosted panel discussion.

About the American Speech-Language-Hearing Association (ASHA)

ASHA is the national professional, scientific, and credentialing association for 223,000 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology support personnel; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists (SLPs) identify, assess, and treat speech, language, and swallowing disorders. http://www.asha.org

View all ASHA press releases at https://www.asha.org/about/press-room/.

Society for Immunotherapy of Cancer to Host Intensive Cancer Immunotherapy and Tumor Immunology Educational Program


News Image

The Cancer Immunotherapy Winter School provides attendees a comprehensive education in cancer immunotherapy for those already in the lab or the clinic.

The Society for Immunotherapy of Cancer (SITC) is pleased to announce the fifth annual Cancer Immunotherapy Winter School, a comprehensive educational program, taking place Jan. 17-21, 2023, in Austin, TX and virtually.

The SITC Cancer Immunotherapy Winter School will feature leading experts in the field who will provide attendees with a deep understanding of the core principles and clinical applications of tumor immunology and cancer immunotherapy. The curriculum covers the fundamentals of cancer immunotherapy and features separate tracks allowing participants to tailor their experience by selecting the educational path most relevant to their learning goals.

“The Cancer Immunotherapy Winter School provides attendees a comprehensive education in cancer immunotherapy for those already in the lab or the clinic,” said SITC President Patrick Hwu, MD. “By continuing to invest in the education and career development of those in the field, we can continue to lay the groundwork of bringing new immune-oncology leaders with a basis for using these skills to improve the lives of cancer patients.”

During the in-person and virtual program, Cancer Immunotherapy Winter School participants will learn about core principles of tumor immunology and cancer immunotherapy, recent advancements in drug and biomarker technologies and their clinical application, clinical and preclinical trial data analysis methods, and best practices in trial design.

In addition to deepening their understanding of integral facets of the field of cancer immunotherapy, attendees will also be able to expand their professional network, developing new relationships with faculty and other thought leaders in this intimate setting through small group breakout sessions.

SITC’s Cancer Immunotherapy Winter School will take place in Austin, TX, Jan. 17–21, 2023. Registration rates and the program schedule are available at sitcancer.org/winterschool.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn and YouTube.

Share article on social media or email:



Capsa Healthcare Announces Kirby Lester KL1Plus Enhancement With Bidirectional Interface to McKesson EnterpriseRx Software


News Image

Kirby Lester KL1Plus With Bidirectional Interface

This new bidirectional interface unlocks the full power of the KL1Plus

Capsa Healthcare, a leading innovator in healthcare delivery solutions for pharmacy and hospital practitioners, announced its Kirby Lester KL1Plus prescription filling device is enhanced with a new bidirectional interface to the widely used McKesson EnterpriseRx pharmacy management software. This is a significant advantage for retail pharmacies to maximize the versatility of the KL1Plus device in pharmacies using EnterpriseRx.

Capsa’s new Kirby Lester bidirectional interface enables pharmacies to fully connect the KL1Plus verification-plus-Rx counting device; Now, all patient prescription filling data will be transported instantly between the KL1Plus and the pharmacy system. EnterpriseRx is a cloud-based system for centralizing a pharmacy’s operations, prescription drug dispensing, data and reporting. EnterpriseRx is a popular system with pharmacies operating multiple locations.

“One of the main reasons a pharmacy runs EnterpriseRx is data management. The same is true for why they now will benefit from installing a Kirby Lester KL1Plus device to physically fill all patient prescriptions. This new bidirectional interface unlocks the full power of the KL1Plus,” says Christopher Thomsen, VP of Business Development for Capsa Healthcare’s Pharmacy Automation Business which includes the Kirby Lester line of automated technology. “Now, with the KL1Plus connected to EnterpriseRx, everything about the status of a prescription fill is tracked and shared in real-time. In the typical hectic environment of today’s pharmacies, this interfacing alleviates tension, avoids Rx filling errors, and improves workflow.”

When a Kirby Lester KL1Plus device is installed in a pharmacy operating EnterpriseRx, the device becomes the main workstation for technicians to fill 100% of patient prescriptions. Once a technician fills a patient script on the KL1Plusd, the device reports back to EnterpriseRx’s pharmacy check function. The new bidirectional interface removes an entire manual step in the process which is a potential source for error and time-waste. The interface also alleviates waiting times at the pharmacy check station. Additionally, the pharmacist reviewing a patient’s filled order will see all processing information for full transparency:

  • Status of each prescription in real-time from start to finish
  • Which pharmacy technician filled the patient’s prescription
  • Time of fill
  • Exact medication filled
  • Exact quantity (partially filled or overcounted scripts will be highlighted)
  • If a double-count was performed (e.g., for a controlled or high-value medication)
  • Any alerts or errors during the filling process
  • The KL1Plus also can act as the pharmacy’s Electronic C-II Log for full management of controlled medications


“Pharmacies operating EnterpriseRx but still filling prescriptions manually are at a disadvantage,” Thomsen says. “With the KL1Plus device taking over all prescription filling and reporting back all data to EnterpriseRx, the pharmacists at that location are empowered with full data and status of every Rx, instantly. This removes ambiguity, guesswork, and hunting for missing data.”

Capsa Healthcare will attend the NACDS Total Store Expo pharmacy conference in Boston, MA, featuring demonstrations of its prescription filling technology.

About Capsa Healthcare

Capsa Healthcare is a worldwide leader in developing and delivering innovative healthcare solutions for a wide spectrum of care providers. With 50+ years of experience, Capsa Healthcare offers a unique ability to meet the demands of diverse healthcare environments and offers a broad range of products including medication carts, medical carts, point-of-care carts, and pharmacy automation solutions. Headquartered in Columbus, OH, Capsa Healthcare has over 400 employees with management, sales, and production offices throughout the world. For more, visit http://www.capsahealthcare.com or call 800-437-6633.

Follow Capsa Healthcare on Facebook (https://www.facebook.com/capsahealthcare/), Twitter (https://twitter.com/CapsaHealthcare), and LinkedIn (https://www.linkedin.com/company/capsahealthcare).

Share article on social media or email:



Author Richard Andrews’s new book “Welcome to Nam” is a personal account of the author’s yearlong tour serving in the Vietnam War told through a series of vignettes


News Image

Richard Andrews, a veteran, has completed his new book “Welcome to Nam”: a gripping and spellbinding memoir of the author’s time overseas during the Vietnam War, and how his experiences stayed with him long after he returned home.

“After returning from Vietnam, I had a lot of nightmares,” writes Andrews. “They started getting so bad that I went to the Veterans Affairs to get help. After a few months, my psychiatrist mentioned for me to start writing them down as soon as I woke up. He then asked if I was getting any compensation for my ears from the land mine? In order to do that I had to tell the Board why I thought I had PTSD. But, to do that, I pretty much had to describe my whole year in Nam! So, I started from the beginning, circling Cam Rahn Bay, and seeing Vietnam for the very first time. I was excited and scared at the same time! I mean. It’s not every day you get to war! I just couldn’t picture someone actually wanting to kill me! I found out in a hurry just how wrong I was!”

Published by Page Publishing, Richard Andrews’s potent tale will transport readers to the front lines of war, where every day could be someone’s last. Expertly paced and full of thrilling moments, “Welcome to Nam” will captivate readers right up until the very end as Andrews relives his experiences for those ready to follow along for the ride.

Readers who wish to experience this mesmerizing work can purchase “Welcome to Nam” at bookstores everywhere, or online at the Apple iTunes Store, Amazon, Google Play, or Barnes and Noble.

For additional information or media inquiries, contact Page Publishing at 866-315-2708.

About Page Publishing:

Page Publishing is a traditional, full-service publishing house that handles all the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing knows that authors need to be free to create, not mired in logistics like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and so on. Page’s accomplished writers and publishing professionals allow authors to leave behind these complex and time-consuming issues and focus on their passion: writing and creating. Learn more at http://www.pagepublishing.com.

Share article on social media or email:

Dr. Kirk Lozada Delivers Exceptional Patient Care With Innovative MirrorMe3D Technology


Dr. Kirkland N. Lozada

Dr. Kirkland N. Lozada, renowned facial plastic and reconstructive surgeon, invests in patient care with innovative MirrorMe3D Technology

Dr. Kirkland N. Lozada, renowned facial plastic and reconstructive surgeon, invests in patient care with innovative MirrorMe3D Technology. As a highly knowledgeable physician with a primary focus on safe and natural results, Dr. Lozada values the availability of comprehensive planning data in a singular platform. While using MirrorMe to care for patients during pre-op, post-op, and everything in between, Dr. Lozada will have the unique opportunity to advance care with greater efficiency. Therefore, Dr. Lozada will be able to monitor patients more thoroughly while gaining additional insight into patient outcomes. Ultimately, Dr. Lozada will use MirrorMe to provide more patients with personalized treatment planning and rapid recovery.

Dr. Kirk Lozada prioritizes high performance, improved surgical outcomes, and quantifiable results with the acquisition of MirrorMe3D Technology. For instance, this technology allows the exact profile reduction to be replicated onto the patient right before the surgery. Additionally, the use of custom made 3D printed post-operative splints improves recovery time and results. If a patient is considering receiving a rhinoplasty, MirrorMe technology and imaging will enable patients to communicate and discuss their results with Dr. Lozada. In addition to intuitive planning tools, advanced analysis, and improved referral connections and surgical care coordination, Dr. Lozada will have access to medical imaging throughout his surgeries. For patients, MirrorMe makes medical data significantly more accessible. Dr. Lozada and his team strongly believe patients should feel empowered to become active participants and decision-makers in their care. MirrorMe technology allows Dr. Lozada’s patients to view their imaging, share their data with other providers, track progress, and view face changes in 3D.

Lozada Facial Plastic Surgery, founded by Dr. Kirk Lozada, is the premier destination for rhinoplasty and facial plastic surgery in Philadelphia. As a Penn Medicine-trained facial plastic surgeon and rhinoplasty expert, Dr. Lozada is recognized among his peers and patients for natural and balanced results. On top of founding his practice, Dr. Lozada is an Assistant Professor at Penn Medicine, a current member of the American Academy of Facial Plastic and Reconstructive Surgery, an editor of two international textbooks, and a faculty member for the Penn Facial Plastic Fellowship program. As a second-generation plastic surgeon, Dr. Lozada follows in his father’s footsteps by giving back through humanitarian work with organizations including Healing the Children Northeast. Dr. Lozada uses his education, training, and passion for innovation to achieve unparalleled results for his patients.

At Lozada Facial Plastic Surgery, a highly skilled team works diligently to help its patients create realistic and effective treatment plans. Innovative MirrorMe3D technology, modern techniques, and compassion are the pillars of care at Lozada Facial Plastic Surgery. Dr. Kirk Lozada and his team routinely perform plastic surgeries, including scarless rhinoplasty, facelift, blepharoplasty, buccal fat removal, chin implant, ear lobe repair, facial fat grafting, brow lift, facial reconstructive surgery, neck lift, lip lift, liposuction, and otoplasty. To schedule a consultation and discuss surgical or non-surgical options, visit https://drkirklozada.com/contact or call (267)817-4600.

Share article on social media or email:

Focus on Lymphoma App Gets New Look and Enhance Tools to Manage Lymphoma Diagnosis


“Technology has become an important tool to manage one’s health and access health information. Focus on Lymphoma has proven invaluable to patients since it provides evidence-based information and resources to help make informed decisions regarding treatment and care.”

The Lymphoma Research Foundation – the nation’s largest non-profit organization devoted exclusively to funding lymphoma research and serving the lymphoma community through education programs, outreach initiatives, and patient services – released features to Focus on Lymphoma, the first mobile application designed to help patients and caregivers better understand and manage their disease.

The new update makes it easier for app users to access their information securely across multiple devices through log-in capabilities and third-party integration with Google. The app’s enhanced medication tracker provides a seamless way for users to track prescriptions through integration with the Food and Drug Administration’s (FDA) National Drug Code (NDC) database. The app also features new tools to assist patients navigating cancer treatment, including a new CAR T Cell Therapy Checklist, intended to help lymphoma patients and caregivers prepare and document their chimeric antigen receptor (CAR) T cell therapy journey.

“Focus on Lymphoma has become a vital resource for members of the lymphoma community, and this new update provides more ways patients and their loved ones can manage a lymphoma diagnosis,” said Meghan Gutierrez, LRF Chief Executive Officer. “Focus on Lymphoma provides the most up-to-date information on lymphoma, new tools to manage treatment, and easy access to the LRF Helpline for enhanced, individualized support and information.”

Focus on Lymphoma continues to provide comprehensive disease information that can be tailored to a person’s particular lymphoma subtype, as well as tools to help track and manage symptoms, blood counts, and doctor appointments. The app was developed based on feedback from members of the lymphoma community and addressed many of the needs of those touched by this blood cancer. The Foundation’s app is an interactive and functional toolkit to help better navigate and manage a lymphoma diagnosis.

“Focus on Lymphoma is an important part of the healthcare process, empowering patients with the tools and knowledge necessary to make the most of their doctor visits,” said Sonali M. Smith, Chair of the LRF Scientific Advisory Board (SAB). “Technology has become an important tool to manage one’s health and access health information. Focus on Lymphoma has proven invaluable to patients since it provides evidence-based information and resources to help make informed decisions regarding treatment and care.”

Focus on Lymphoma is a free app available for Apple iPhone and iPad. It is also available for Android phones and tablets. For more information or to download the Lymphoma Research Foundation’s Focus On Lymphoma app, visit lymphoma.org/focusonlymphoma.

Share article on social media or email: